The Systemic Anti-Cancer Therapy (SACT) team at Public Health England has released the final version of the workbook with the following documents: Companion brief detailing the official trust comments on their data Evaluation report describing the feedback received from trusts … Read More
We are pleased to announce that Tom Newsom-Davis has been appointed Vice Chair of the BTOG Steering Committee. Tom is a consultant in medical oncology at Chelsea and Westminster Hospital, London, where he specialises in thoracic malignancies. He has been … Read More
Each year the British Thoracic Oncology Group (BTOG) gives a lifetime achievement award to an individual who in the steering committee’s opinion has made a significant contribution to the management of thoracic malignancies in the UK and Ireland. The award … Read More
We send a regular newsletter by email to those of our members who subscribe, click here to see the latest issue. Click here to join and subscribe and get your own BTOG E-News in your inbox.
The BTOG Position Statement 2018 is now available. This document provides the brief background of BTOG and achievements to date and confirms BTOG’s Core Principles and Key Activities. Please view here. British Thoracic Oncology Group Position Statement Final July 2018
The Second Edition of the IASLC Staging Manual in Thoracic Oncology reports on the latest revisions of the tumor, node and metastasis (TNM) classifications of thoracic malignancies, namely, lung cancer, malignant pleural mesothelioma, carcinoma of the esophagus and of the … Read More
BTOG distributed this EORTC survey to our members and the resulting article has just been published: Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of … Read More
Download the BTOG Annual Report (April 2016 to March 2017).
Article from the European Journal of Cancer: Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial Please see article.
ASCO 2017 National Update – Roy Castle Lung Cancer Foundation in partnership with BTOG Friday 9th June 2017 – Wellcome Collection, London The main focus for this Roy Castle Lung Castle Foundation meeting, planned in partnership with the British Thoracic … Read More